What's on the web on your pursuit, hobbies, interests and worries

HepatocellularCarcinoma news

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges ...


Dove Medical Press - Nov 8, 2017
Abstract: The only US Food and Drug Administration (FDA)-approved first-line systemic therapy for hepatocellular carcinoma (HCC) is sorafenib; however, resistance or intolerance to sorafenib is unfortunately common. In this review, we briefly describe ...
 

Regorafenib not cost-effective as second-line therapy for hepatocellular carcinoma


Healio - Nov 8, 2017
Although clinically effective, the use of regorafenib as second-line therapy for hepatocellular carcinoma did not appear cost-effective, according to study results. Regorafenib (Stivarga, Bayer) demonstrated an incremental cost-effectiveness ratio ...
 

SIRT Does Not Improve Overall Survival vs Sorafenib in Hepatocellular Carcinoma


Cancer Therapy Advisor - Oct 27, 2017
Selective internal radiotherapy (SIRT) with yttrium-90 (90Y) resin microspheres did not prolong survival among patients with advanced- or intermediate-stage hepatocellular carcinoma (HCC) after unsuccessful chemoembolization, according to a study ...
 

Hepatocellular Carcinoma - premium items on eBay

USED (GD) Hepatocellular Carcinoma by W. Y. Lau


 

NEW Hepatocellular Carcinoma by W. Y. Lau


 

NEW Hepatocellular Carcinoma:: Targeted Therapy and Multidisciplinary Care


 

>> Go to all great Hepatocellular Carcinoma deals on eBay


Hepatocellular Carcinoma pictures on the web

>> Show

Hepatocellular Carcinoma videos

Hepatocellular Carcinoma


Please watch: \
 

Hepatocellular Carcinoma: Optimal Treatment and Transplantation


Monday, February 3, 2014 Presented by Gabriel T. Schnickel, MD About the Henry Ford Transplant Institute Lecture Series The Henry Ford Transplant Institute is ...
 

Histopathology Liver--Hepatocellular carcinoma in cirrhosis


Histopathology Liver--Hepatocellular carcinoma in cirrhosis of the liver.
 

Update in the Clinical Management of Hepatocellular Carcinoma


A Department of Medicine Grand Rounds presented by Augusto Villanueva, MD, PhD, Assistant Professor of Medicine (Liver Diseases).
 

LIVER CANCER, HEPATOCELLULAR CARCINOMA, AND HEPATOMA by Dr. Robert Gish.


In this mini lecture, Dr. Gish discusses three different liver complications; Liver Cancer, Hepatocellular Carinoma, and Hepatoma. Hepatocellular carcinoma is ...